Cite
HARVARD Citation
Yendewa, G. et al. (2020). A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5 mg/g viscosified gel formulation versus a modified formulation. Journal of global antimicrobial resistance. pp. 171-180. [Online].